BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6168728)

  • 1. Factor XII assay with the chromogenic substrate chromozym PK.
    Dick W; Cullmann W; Müller N; Adler K
    J Clin Chem Clin Biochem; 1981 Jun; 19(6):357-61. PubMed ID: 6168728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of factor XII and plasma prekallikrein with chromozym PK].
    Stürzebecher J; Klessen C; Markwardt F
    Z Med Lab Diagn; 1982 Oct; 23(5):306-11. PubMed ID: 6924817
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay for Hageman factor (factor XII) in human plasma by means of chromogenic substrate for plasma kallikrein.
    Egberg N; Overmark-Berggren I
    Thromb Res; 1983 Sep; 31(6):875-80. PubMed ID: 6557688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An automated chromogenic peptide substrate assay for coagulation factor XII.
    Jones DW; Gallimore MJ; Winter M
    Blood Coagul Fibrinolysis; 1998 Mar; 9(2):183-7. PubMed ID: 9622217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new assay for the determination of factor XII in plasma using a chromogenic substrate and a selective inhibitor of plasma kallikrein.
    Stürzebecher J; Svendsen L; Eichenberger R; Markwardt F
    Thromb Res; 1989 Sep; 55(6):709-15. PubMed ID: 2781533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chromogenic substrate assay kit for factor XII: evaluation and use for the measurement of factor XII levels in cardiopulmonary bypass patients.
    Gallimore MJ; Jones DW; Wendel HP
    Thromb Res; 1999 Apr; 94(2):103-9. PubMed ID: 10230895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of factor XII in plasma using the kallikrein substrate chromozym PK.
    Klessen C; Stürzebecher J; Markwardt F
    Thromb Res; 1982 Mar; 25(6):501-5. PubMed ID: 6921902
    [No Abstract]   [Full Text] [Related]  

  • 9. A microtitre chromogenic substrate assay for factor XII.
    Walshe KJ; Mackie IJ; Gallimore M; Machin SJ
    Thromb Res; 1987 Aug; 47(3):365-71. PubMed ID: 3629562
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on plasma prekallikrein assay method with chromogenic substrates (S-2302)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1983 Feb; 31(2):219-22. PubMed ID: 6190027
    [No Abstract]   [Full Text] [Related]  

  • 11. John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study.
    Koster T; Rosendaal FR; Briët E; Vandenbroucke JP
    Br J Haematol; 1994 Jun; 87(2):422-4. PubMed ID: 7947293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials.
    van der Kamp KW; van Oeveren W
    J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a chromogenic substrate assay for the determination of hirudin in plasma.
    Spannagl M; Bichler J; Birg A; Lill H; Schramm W
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):121-7. PubMed ID: 1772979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between factor XII, von Willebrand factor and postoperative deep vein thrombosis.
    Nilsson T; Mellbring G; Hedner U
    Acta Chir Scand; 1986 May; 152():347-9. PubMed ID: 3090810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct assay of factor XIIa in plasma with synthetic chromogenic substrates.
    Kluft C; Svendsen L; Los P
    Adv Exp Med Biol; 1983; 156():201-4. PubMed ID: 6190367
    [No Abstract]   [Full Text] [Related]  

  • 17. Automated prothrombin-time test with use of a chromogenic peptide substrate and a centrifugal analyzer.
    Becker U; Jering H; Bartl K; Jilek F
    Clin Chem; 1984 Apr; 30(4):524-8. PubMed ID: 6705195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302.
    Ito R; Statland BE
    Clin Chem; 1981 Apr; 27(4):586-93. PubMed ID: 6907061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of factor XII in human plasma using prekallikrein or the chromogenic peptide S-2222 as substrates--significance of the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1989 May; 54(3):197-205. PubMed ID: 2787541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.